-transparent.png){kind=logo}
80 cases of anti-Rho(D) treatment after mismatched transfusions are reviewed to compare the intramuscular (i.m.) and intravenous (i.v.) route of treatment. No severe reactions such as renal failure occurred with either method of anti-D treatment. If the Rh-immune globulin is injected i.m., 20 micrograms anti-D per ml red cells are used. For i.v. anti-D administration, 10-12 micrograms anti-D are suggested. The i.v. method of anti-D treatment is recommended for the future. Furthermore, a scheme of treatment for after mismatched transfusions is described.
Related Publications
J Ennker, and
D H Maas, and
J Schneider
September 1968,
Canadian Medical Association journal,
J Ennker, and
D H Maas, and
J Schneider
December 1970,
Deutsche medizinische Wochenschrift (1946),
J Ennker, and
D H Maas, and
J Schneider
November 1968,
The Medical letter on drugs and therapeutics,
J Ennker, and
D H Maas, and
J Schneider
October 1995,
Bone marrow transplantation,
J Ennker, and
D H Maas, and
J Schneider
September 1976,
Deutsche medizinische Wochenschrift (1946),
J Ennker, and
D H Maas, and
J Schneider
January 1965,
Bibliotheca haematologica,
J Ennker, and
D H Maas, and
J Schneider
February 2002,
Transfusion,
J Ennker, and
D H Maas, and
J Schneider
November 2002,
Transfusion,
J Ennker, and
D H Maas, and
J Schneider
January 1962,
Bibliotheca haematologica,
J Ennker, and
D H Maas, and
J Schneider
August 2000,
Lancet (London, England),
